Echo Therapeutics, Inc. Announces First Quarter 2014 Financial Results and Regulatory and Product Development Update

[PR Newswire] – PHILADELPHIA, May 9, 2014 /PRNewswire/ — Echo Therapeutics, Inc. (Nasdaq: ECTE), a medical device company developing its Symphony ® CGM System as a non-invasive, wireless continuous glucose monitoring … more

View todays social media effects on ECTE

View the latest stocks trending across Twitter. Click to view dashboard

See who Echo is hiring next, click here to view